Search results
Found 1080 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Key step for hepatitis research as patient database created
General Research
11 December 2020
For the first time, a comprehensive database comprising an initial cohort of more than 1,300 patients with chronic hepatitis B or hepatitis C infections has been developed for potential future research into the conditions.
University of Oxford awarded major European Research Council funding
Awards and Appointments General Research
9 December 2020
European Research Council grants worth more than €16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
Clinical Trials Coronavirus COVID-19 General Research
8 December 2020
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
Hidden damage to lungs from COVID-19 revealed in new research study from University of Oxford & Sheffield
Coronavirus COVID-19 General Research
2 December 2020
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
SCALOP team discover new pancreatic cancer biomarker
General Research
30 November 2020
The discovery of pancreatic cancer biomarkers (naturally occurring molecules, genes or characteristics which can be used to confirm the presence or predict the outcome of a cancer) is vital in understanding patient outcomes and finding new therapeutic targets.
A clue to how a memory-enhancing pill might work
General Research
27 November 2020
Hundreds of dietary supplements have been reported to improve cognitive and emotional function in humans, but few have scientific foundation. A new study from the Department of Physiology, Anatomy & Genetics (DPAG) provides fresh insight into how dietary magnesium supplementation can influence memory performance.
Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial
Coronavirus COVID-19 General Research
27 November 2020
In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication.
New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy
General Research
25 November 2020
New research led by Department of Physiology, Anatomy & Genetics researcher Dr Kerstin Timm shows that a recently developed imaging technique can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.
Oxford vaccine team shortlisted for parliamentary awards
Awards and Appointments Coronavirus COVID-19 Research
24 November 2020
The University of Oxford team who have developed a COVID-19 vaccine in record time have been shortlisted for the Excellence in Healthcare Award at the NHS Parliamentary Awards.
Oxford University breakthrough on global COVID-19 vaccine
Coronavirus COVID-19 General Research
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
People in prison should be prioritised for any COVID-19 vaccine
Coronavirus COVID-19 General Research
20 November 2020
Preventing serious complications from COVID-19 in potentially vulnerable populations in high risk environments, such as prisons, and preventing spread to surrounding communities needs a coordinated evidence-based approach to managing outbreaks of COVID-19 in prison settings.
Prior COVID-19 infection offers protection from re-infection for at least six months
Coronavirus COVID-19 General Research
20 November 2020
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection.
Transplant kidney survival rate improves with new method of transportation
General Research
20 November 2020
New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.
Viruses shown to evolve as a result of different immune responses in different ethnic populations
Coronavirus COVID-19 General Research
20 November 2020
New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.
Oxford coronavirus vaccine produces strong immune response in older adults
Clinical Trials Coronavirus COVID-19 General Research
19 November 2020
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
Return to school sees improvement in children's mental health
Coronavirus COVID-19 General Research
17 November 2020
Mental health difficulties in children increased during the first national lockdown (between March and June 2020), but have decreased since.
Interferon-b trial shows positive results
Clinical Trials Coronavirus COVID-19 General Research
16 November 2020
A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients.
Oxford University and PHE confirm high-sensitivity of Lateral Flow Tests following extensive clinical evaluation
Coronavirus COVID-19 General Research
12 November 2020
Extensive clinical evaluation from Public Health England and the University of Oxford show Lateral Flow Tests are accurate and sensitive enough to be used in the community, including for asymptomatic people.
Oxford ramps up COVID-19 testing capability
Coronavirus COVID-19 General Research
10 November 2020
The University of Oxford has joined forces with Thermo Fisher Scientific, the world leader in serving science, to ramp up the university’s capacity to deliver COVID-19 testing data.